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ABSTRACT 
A cadre of experts and stakeholders from government agencies, professional organizations, emer-
gency medicine and response, pediatrics, mental health, and disaster preparedness were gathered to 
review and summarize the existing data on the needs of children in the planning, preparation, and 
response to disasters or terrorism. This review was followed by development of evidence-based con-
sensus guidelines and recommendations on the needs of children in disasters, including chemical, bi-
ological, and radiological terrorism. An evidence-based consensus process was used in conjunction 
with a modified Delphi approach for selection of topic areas and discussion points. These recommen-
dations and guidelines represent the first national evidence-based standards for pediatric disaster 
and terrorism preparedness. 
T HE NEEDS OF CH ILDREN must be considered during planning and preparation for d isaste rs and terrorist 
events. There are unique pediatric considerations that 
need to be addressed during this process: 
• The developmental abilities and cognitive levels of 
children may impede their ability to escape danger. 
Children have unique psychological vulnerabilit ies. so 
special management plans are needed in the event of 
mass casualt ies and evacuation. 
Emergency medical service (EMS), medical, and hos-
pital slaff may not have pediatric training. equipment, 
or facilities available. 
With respect 10 planning for and responding to terrorism 
events, children have unique vulnembilities and require 
specific equipment and interventions that musl be consid-
ered. In addition, emergency responders, medical profes-
sionals, and health-care institutions require special exper-
ti se and training 10 ensure optimal care of children who are 
exposed to biological, chemical, or nuclear agenls. Exam-
ples of the considerations relevant to children include: 
Children cannOl be deconlaminated in adu lt decontal11-
inalion units. 
Chi ldren are more vulnerable to chemical agents that 
are absorbed through the skin or are inhaled. 
Ch ildren have special susceptibilities to dehydration 
and shock from biological agents. 
Children require d iffe rent dosages or different antibiot-
ics and 3ntidoles to many agents. 
Children are more susceptib le to the effects of radia-
tion exposure and require a more vigorous medical re-
sponse than do adults. 
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These unique pediatric needs have rarely been consid-
ered in previous planning and preparedness efforts I and 
may not be sufficiently understood or considered in cur-
rent disaster planning. This is especially true for the spe-
cific challenges associated with recognizing and re-
sponding to biological, chemical, or nuclear weapons. 
Also, far less has been done to create support systems 
specifically for children compared with such systems for 
adults. Therefore, the current adult models and guide-
lines cannot be applied to the care of children. Rather, it 
is essential to define the needs of children and to develop 
plans that specifically address their care. 
DISASTER PLANNING 
Integrating pediatric needs into federal, state, regional, 
and local disaster planning is critical. According to un-
published data produced by FEMA in 1997, no state dis-
aster plans included pediatric issues at that time. Disaster 
planning must consider the needs of children in various 
settings, including children who are at home, in school or 
daycare, or in transit, as weII as children who for various 
reasons cannot be reunited with their families. Children 
with special health-care needs are particularly vulnera-
ble, especially if their survival depends on medications or 
technologies (e.g., respirators) that may not be readily 
available during an emergency. 
The literature addressing the needs of children in disas-
ters and disaster planning is sparse. The body of literature 
concerning disaster events, or response and planning for 
disasters, almost exclusively addresses the needs of 
adults. Some limited -studies of the needs of children in 
disasters have been done, but few go beyond identifying 
and treating posttraumatic stress disorder (PTSD).2-9 A 
MEDLINE search of articles published during the past 
20 years, using the keyword "disaster," found more than 
4,000 entries. However, only 350 of these entries con-
cerned children, and close to 95% of those reported pri-
marily on PTSD. Thus, while it is clear that there is a ba-
sic body of literature on PTSD in children, there are only 
a few articles on other aspects related to children and dis-
asters. 
A review article for Critical Care Clinics in 1991 by 
Holbrook et a1. 10 was one of the first that attempted to de-
fine some of the unique aspects of the response to the 
needs of children in disasters. While based on only lim-
ited evidence, this article provided some basic informa-
tion that can guide future study. An article from England 
by Carley reported the results of a Delphi study used to 
identify and improve areas of concern in medical care for 
children during the planning, response, and recovery 
phases of major incidents. II This was not data-based but 
represents the well-formulated recommendations from a 
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consensus of experts. The authors concluded that "the 
common theme is not that planning for children failed but 
rather that planning for children did not exist." Mack-
way-Jones then published a paper describing how the 
Delphi study and consensus recommendations could be 
implemented to improve care for children. 12 The benefit 
of this article is that it "presented a logical approach on 
how to incorporate these recommendations to allow for 
planning of the rare but potentially devastating effects of 
a major incident involving children." 
Evidence-based studies 
There also have been a limited number of studies based 
on evidence obtained from actual disasters (described be-
low). While not global in scope, these articles highlight 
the needs of children and provide concepts for studying 
whether these needs are met in specific disaster incidents. 
In 1993, van Amerongen et a1. 13 studied the EMS re-
sponse to a plane crash that had 135 survivors, 22 of 
whom were children. These authors found that children 
were not adequately triaged or transported to appropriate 
facilities that had been designated for children before the 
event. The authors called for higher levels of pediatric 
planning within the existing disaster plan. In 1994, Quinn 
et a1. 14 reported that Hurricane Andrew was associated 
with an increase in admissions to a pediatric emergency' 
department for open wounds, kerosene ingestions, and 
gastrointestinal illness. The authors recommended pa-
tient education to lower risk after similar devastating or 
disruptive events. 
Takeda et al. 15 retrospectively reviewed the impact of a 
major earthquake in Japan on the condition of 678 fami-
lies of children with special health-care needs. These 
authors identified unmet needs and problems for the fam-
ilies. Shimada and Funato studied 28 children on me-
chanical ventilation who lived through the same major 
Japanese earthquake. 16 Although none of the children 
died, 19 had major medical problems during and after the 
earthquake, and the need for better planning and prepara-
tion was recognized. Lamburg l7 examined the intensive, 
prolonged, and complicated psychological needs experi-
enced by children after the violence associated with the 
Waco and Dunblane events. The conclusion was that 
there was no easy solution to this problem and that sig-
nificant resources would be required to provide real sup-
port in this and similar settings. 
Damien et a1. 18 gave a firsthand account of a pediatric 
relief team that traveled to St. Thomas immediately after 
a major hurricane. The team took care of 100 patients 
daily, ranging from critically ill children to those with 
open wounds or routine problems. These authors demon-
strated the value of Disaster Medical Assistance Teams 
(DMATs) focused on the needs of children, and they 
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called for significant training of such teams to function in 
austere environments. 
Policy guidelines from professional societies 
Only recently have professional organizations begun to 
develop policy guidelines considering the needs of chil-
dren during and after disasters. Such policies tend to fo-
cus on the roles of specific providers in disaster planning, 
preparation, and response. Examples would be state-
ments from the American Academy of Pediatrics such as 
The Pediatrician's Role in Disaster Preparedness and 
How Pediatricians Can Respond to the Psychosocial Im-
plications of Disasters. 19,20 
Policy statements by national professional organiza-
tions are not comprehensive in scope and are often based 
on little actual evidence. As such, they represent only a 
"best advice" approach. Furthermore, such policies do 
little to ensure an organized response to pediatric disas-
ters, unless they are both explicitly endorsed by local 
public health and safety authorities and fully integrated 
into local disaster preparedness initiatives. 
Need for a consistent approach 
Without a consistent approach from state to state, it 
will be difficult, if not impossible, for national pediatric 
professional organizations to educate their members 
about their roles and responsibilities during disasters af-
fecting children. Furthermore, a consistent national ap-
proach is needed to empower state offices of emergency 
management, local public health and safety authorities, 
local chapters of national pediatric professional organiza-
tions, and members of such organizations to accomplish 
a number of tasks, including: 
• conceptualizing and integrating the roles and responsi-
bilities of pediatric health professionals during natural 
or technological disasters; 
• building partnerships that will allow a rapid and inte-
grated response to a disaster; 
• conducting the advance planning that is necessary to 
ensure a timely and appropriate response by the in-
volved parties; and 
• collaborating effectively in time of need. 
TERRORISM PLANNING 
It is even more important to consider children in terror-
ism planning and preparedness than in traditional disaster 
planning. Thinking formerly was focused on military 
personnel as the potential victims of biological, chemi-
cal, or radiological attacks. Thus, the treatments, anti-
dotes, and research needed to help such victims were 
based on the needs of adults. Unfortunately, today the en-
tire population, including communities, families, and 
children, are at risk of experiencing a terrorist event that 
involves biological, chemical, or radiological weapons. 
As a result, current efforts must include research, plan-
ning, and preparation for pediatric victims of terrorist 
events. 
Emergency planners and emergency responders must 
shift their thinking to include the care of all victims in 
times of terrorist events. This includes considering chil-
dren as possible victims and planning for their needs dur-
ing training and equipment allocation. Most important, 
emergency planners and responders cannot approach the 
care of children by simply modifying current practices. 
The unique anatomy and physiology of children necessi-
tates a unique approach to assessment and treatment, in-
cluding the use of pediatric-specific equipment and med-
ications, which must be dosed appropriately according to 
age and weight. 
As with general planning for disasters, a consistent ap-
proach among states is needed to address the needs of 
children during terrorist events. Otherwise, it will be dif-
ficult, if not impossible, for providers to learn about their 
specific roles and responsibilities during disasters affect-
ing children. In addition, plans and stockpiles need to ad-
equately address the needs of children. And consistency 
is needed in evaluation models and exercises and drills to 
test disaster and terrorism preparedness for children. 
Evaluating the existing data on the needs of children in 
disasters and formulating appropriate guidelines and rec-
ommendations are necessary to correct deficiencies in 
national planning for the impact of terrorism on children. 
Unfortunately, as with disaster planning, there is a sparse 
literature addressing terrorism preparedness and the 
needs of children. This topic was covered somewhat in a 
review on chemical-biological terrorism and children.21 
However, an article describing medical preparedness for 
terrorist incidents at the Atlanta Olympics, along with 
recommendations for such events, did not address chil-
dren and their special needs, nor did it reference other re-
sources that did.22 A series of important policy and re-
view papers on biological and chemical warfare also 
failed to address pediatric issues.23-25 Consensus must be 
established in those areas for which data do not exist, and 
a research agenda to fill the identified voids must be de-
veloped and implemented. 
The Public Health Security and Bioterrorism 
Preparedness and Response Act 
In 2002, the President signed the Public Health Secu-
rity and Bioterrorism Preparedness and Response Act. 
This Act started the process of improving our bioterror-
ism preparedness, but the attention to pediatrics was lim-
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ited. The only specific consideration of children was in 
the creation of a National Advisory Committee on Chil-
dren and Terrorism (NACCT) (for which the authors 
serve as consultants). The objective of the NACCT, as 
specified in the legislation, is to assess and provide rec-
ommendations to the Secretary of the Department of 
Health and Human Services in a number of areas: 
• The preparedness of the health-care system to respond 
to bioterrorism as it relates to children; 
• Needed changes to the health-care and emergency 
medical service systems, including protocols to meet 
the special needs of children; and 
• Changes, if necessary, to the National Strategic Stock-
pile (under section 121 of the Act) to meet the emer-
gency health needs of children. 
While this provision was helpful in providing recommen-
dations to the Secretary, it neither required that such rec-
ommendations be enacted nor provided funding for them. 
All other sections of the Act were implemented almost 
immediately, but the advisory committee on children and 
terrorism was not appointed until March 2003, and this 
committee had only until June 2003 to issue a final re-
port. Therefore, the committee based their focus areas, 
recommendations, and guidelines on those developed at 
the consensus conference and presented in this article. 
This decision was made in an effort to achieve maximal 
efficiency using the most current national information 
available. 
METHODOLOGY 
The methodology used to develop the guidelines and 
recommendations in the current report was one of a pre-
viously validated evidence-based consensus process26 
that has been used in prior studies, supplemented by a 
modified Delphj27-30 approach for topic selection. We 
convened experts from multiple disciplines and areas of 
expertise involved in the planning for and care of chil-
dren during times of disaster and terrorist events. This 
process had several goals: 
• Build collaboration among individuals with expertise 
in pediatrics, pediatric emergency medicine, pediatric 
critical care, pediatric surgery, and emergency man-
agement (including disaster planning, management, 
and response). 
• Review and summarize the existing data on the needs 
of children in disaster planning, preparation, and re-
sponse. 
• Develop evidence-based guidelines and recommenda-
tions on the needs of children in disasters, and develop 
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evidence-based consensus guidelines for dealing with 
gaps in the evidence. 
• Create a research agenda to address knowledge gaps 
based on the limited data that exist on the needs of chil-
dren in disasters. 
Panel selection 
An initial planning meeting was held in the winter of 
2002. The overall aim was to identify a multidisciplinary 
group of experts in the field of pediatric emergency pre-
paredness and to develop a conference format and agenda. 
At this meeting, panel co-chairs were selected, and the 
format and composition of the consensus panel were es-
tablished. 
All panelists were selected on the basis of research or 
clinical expertise in pediatrics and emergency prepared-
ness, as well as their position as "thought leaders" in this 
emerging field. The participants in this process were se-
lected before the topics were selected, and participants 
represented a cross-section of those with expertise, re-
sponsibility, and authority to make decisions that would 
affect pediatric preparedness for disaster and terrorist 
events. Participants also had expertise regarding the ef-
fects of biological, chemical, and radiological terrorism on 
children. Many also had knowledge and expertise regard-
ing the psychological stress faced by children and families 
since September 11. Participants included representatives 
from various pediatric health organizations, including: 
• Representatives from relevant professional organiza-
tions; 
• Representatives of multiple federal, state, and local 
government agencies involved with disaster and terror-
ism preparedness; and 
• Experts in the fields of emergency medicine, pediatrics 
and its subspecialties, pediatric disaster medicine, nurs-
ing, social work, mental health, and emergency man-
agement. These included recognized national experts in 
relevant subject areas. 
Staff members from the Children's Health Fund and the 
Program for Pediatric Preparedness provided support for 
both the process and the face-to-face meeting. The names 
of potential experts were provided by specialty societies. 
Authorship on key publications was considered during 
the selection process. The final consensus panel com-
prised 72 experts from a wide range of disciplinary back-
grounds. Each panelist fulfilled the aforementioned crite-
ria and is currently involved in research on or practice of 
emergency preparedness. Attendance for the entire time 
of the consensus conference meeting was required. The 
names of the organizations, agencies, and representatives 
can be found in Appendix A. 
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Topic selection 
The topics to be covered by the consensus process and 
for which recommendations and guidelines were to be 
developed were selected using a modified Delphi ap-
proach. The modified Delphi process included submis-
sion of topics, followed by three rounds of voting by the 
planning committee to determine the top eight areas for 
discussion and the sUbtopics for each. 
Literature review 
Six months before the consensus meeting, group lead-
ers were selected to review and grade the literature (with 
the assistance of grant staff) and to develop a rating sys-
tem for recommendations. Grading and rating used the 
evidence-based scoring system published by the Ameri-
can College of Critical Care Medicine (Figure 1).31 The 
literature was generated by a MEDLINE search using the 
following age-limited keywords/phrases: disaster, terror-
ism, preparedness, bioterrorism, chemical terrorism, ra-
diological terrorism, and disaster mental health. Because 
the available pediatric data were scarce, the search was 
then expanded by removing the age limitation. 
The consensus meeting 
The consensus panel meeting in Washington, DC, con-
sisted of closed-session deliberations that involved sev-
eral key decision-making components. Before the confer-
FIGURE I. AMERICAN COLLEGE OF CRITICAL CARE 
MEDICINE GUIDELINES FOR RATING LITERATURE AND 
RECOMMENDATIONS BASED ON QUALITY AND 
STRENGTH OF EVIDENCE 
Rating system for references 
A. Randomized, prospective controlled trials 
B. Nonrandomized, concurrent, or historical cohort 
investigations 
C. Peer-reviewed, state-of-the-art articles, review ar-
ticles, editorials, or substantial case series 
D. Non-peer-reviewed published opinions, such as 
textbook statements or official organizational pub-
lications 
Rating system for recommendations 
Level I: Convincingly justifiable on scientific evi-
dence alone 
Level II: Reasonably justifiable by scientific evi-
dence and strongly supported by expert 
critical care opinion 
Level III: Adequate scientific evidence is lacking but 
widely supported by available data 
ence, all panelists were provided with a complete bibli-
ography, as well as summaries of the available evidence 
within their topic areas. A meeting agenda and list of ob-
jectives also were provided in advance. At the confer-
ence, panelists were provided with the evidence-based 
summaries of all topics, as well as the primary literature 
sources. 
The meeting, which lasted more than 40 hours, was 
conducted using a previously validated evidence-based 
approach, according to the following format: 
• Experts in the subject area to be addressed presented 
baseline evidence (including evidence review and 
grading); 
• Breakout groups were formed for focused discussion 
on topics within each subject area; and 
• The entire group reconvened to review conclusions 
reached by each breakout group and to develop formal 
recommendations and guidelines. 
The consensus development method employed at this 
meeting involves intensive review of specific topic areas 
by expert panels, structured group discussions, and con-
sensus voting according to a strict mathematical for-
mula. The approach is widely referred to as the Rand 
method for medical decision-making and technology as-
sessment. Fundamental elements include panel selec-
tion, development of appropriateness scales and panel 
preparation, and the modified Delphi technique for topic 
selection coupled with group decision-making and con-
sensus development. This approach synthesizes the 
opinions of clinicians and research experts and is de-
signed to develop consensus guidelines for a broad range 
of clinical situations. The advantages are cost-effective-
ness and timeliness, as the method draws on a broad 
base of clinical and research data. The principal disad-
vantages are the limitations of currently available data 
and the subjective nature of the group decision-making 
process. 
The recommendations and guidelines 
The recommendations and guidelines were drafted us-
ing the approach already discussed. This process began 
with a review of current epidemiological data on pedi-
atric preparedness. Subsequently, the panel began con-
sensus deliberations, using the Rand methodology, for 
development of the treatment recommendations and 
guidelines. Panelists were invited to base judgments on 
personal opinions about the evidence, not on the position 
of the society that may have nominated them. 
A staged approach was used to achieve this consensus. 
In the first stage, panelists voted on whether a particular 
guideline or recommendation was appropriate. If no 
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agreement was reached, further discussion occurred and 
the vote was retaken. A maximum of two votes was per-
mitted on any specific issue. Conference attendees then 
commented on the draft recommendations and guide-
lines, which were modified accordingly. This process 
was continued until consensus was reached. 
During the meeting, "consensus" for any specific or 
general recommendation or guideline was defined as dis-
agreement by only 10% or less of attendees. In actuality, 
agreement was unanimous on all recommendations and 
guidelines. 
It is important to remember that the group leaders iden-
tified almost no randomized controlled trials in children 
relating to disaster and terrorism preparedness, except for 
those addressing mental health considerations (as noted 
above). Because of this lack of data from randomized tri-
als in children, many of the recommendations in this doc-
ument represent either extrapolations from adult data, an 
application of non preparedness research to preparedness 
guidelines, or expert opinion rather than irrefutable evi-
dence. 
Following the meeting, the final report from each sub-
committee was compiled into a comprehensive docu-
ment by the group leader, a process that took 6 months. 
Final copyediting and review were performed by the 
authors. 
RESULTS 
The final recommendations of the conference focused 
on eight major areas: 
1. Emergency and prehospital care 
2. Hospital care 
3. Terrorism preparedness and response 
3.1. Biological terrorism 
3.2. Chemical terrorism 
3.3. Radiological terrorism 
3.4. Physical protection 
3.5. Decontamination 
3.6. Strategic National Stockpile (SNS) 
The specific recommendations can be found below. 
Emergency and prehospital care 
The cornerstone of emergency preparedness and ter-
rorism response rests with the first responders. They pro-
vide not only the initial care but also the initial assess-
ment. This is critical to ensure that all patients receive the 
care they need, while appropriately allocating scarce re-
sources during disaster and terrorist events. Therefore, 
any emergency response planning must begin with well-
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trained and well-equipped first responders who are pre-
pared to perform triage and to provide the needed care. 
Figure 2 presents recommendations that address the min-
imal elements for proper triage and prehospital care of 
children by first responders. 
Hospital care 
Medical preparedness depends on a combination of 
public health direction and general hospital preparedness. 
Hospital preparedness encompasses a wide range of is-
sues, including preparedness of both the physical facility 
and the staff. The hospital also serves as a regional re-
source to other health-care facilities, as well as the med-
ical oversight and training resource for first responders. 
In addition, hospitals are a key resource of trained staff 
who may be needed in times of emergency, or by other 
facilities, or both. 
Specialty resource centers also play an important role 
in emergency preparedness. Specialty resource centers 
are defined as facilities with unique capabilities beyond 
those expected of any general hospital and that have re-
ceived designation in a specific area of expertise from an 
appropriate accrediting organization. Examples include 
trauma centers, bum centers, hyperbaric centers, and pe-
diatric critical care centers. 
All of the above elements are important considerations 
with regard to the needs of children. During a disaster or 
terrorist event, children will undoubtedly arrive at general 
hospitals, so all hospitals must be prepared for a greater 
number of pediatric victims than usual. Specialty centers 
must also be prepared for increased pediatric needs. Staff 
and physician volunteer programs that are key to ensuring 
adequate numbers of providers must also recognize the 
need for more pediatric-trained providers. Currently, the 
availability of providers who have pediatric training is 
limited. The recommendations found in Figures 3 and 4 
address hospital preparedness, specialty centers, physi-
cian volunteers, and the role of the children's hospital. 
Biological, chemical, and radiological terrorism 
preparedness 
Once the general needs of children have been ad-
dressed, preparedness specifically for a terrorist event 
must be considered. The unique physiology and anatomy 
of children make them more susceptible to terrorist 
agents, and unique therapies may be required. 
Biological terrorism. The consensus panel agreed that 
all plans for providing bioterrorism medication must in-
clude all medications listed in Tables 1 and 2, including 
appropriate pediatric forms and dosages. This would in-
clude stocking and deployment of these agents (push 
packs, vendor-managed inventory, etc.) through the SNS 
and state and local health departments. The panel also 
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FIGURE 2. RECOMMENDATIONS FOR TRIAGE AND PREHOSPITAL CARE 
Triage 
• Incorporate use of a pediatric-specific triage system 
by all first responders and hospital personnel. At this 
time, JumpST ART Pediatric Multiple Casualty Inci-
dent Triage is the only objective triage system that 
addresses the needs of children. It provides guidance 
for triage personnel making potential life-and-death 
decisions that otherwise may be influenced by emo-
tional issues when triaging children. 
• Designate a pediatric-specific triage process (cur-
rently, JumpSTART, as described above) for use 
in training by first responders and emergency per-
sonnel. 
• Continue to develop, improve, and implement 
triage systems that are objective and child-specific 
to advance the efficiency and accuracy of triage. 
• Ensure integration and consistency of use of pedi-
atric triage processes among local, state, and fed-
eral responders, including Disaster Medical Assis-
tance Teams (DMATs). 
• Develop and use pediatric-specific triage systems 
that address primary, secondary, and tertiary triage. 
agreed that there should be treatment provisions for local 
responders. The consensus process further defined the 
chemotherapy and chemoprophylaxis protocols listed in 
Tables I and 2. 
The issues of immunotherapy and immunoprophylaxis 
also were reviewed. The committee concluded that 
provision must be made for the study and use of inves-
tigational vaccines in children. The currently licensed 
These should address all aspects of disaster triage, 
including psychological triage, triage for weapons 
of mass destruction (WMD), and triage for chil-
dren with special health-care needs. 
• Include evaluation of triage processes and perfor-
mance in quality assessment procedures (per-
formed after the event) at local and state levels, as 
well as in future research initiatives. 
Prehospital Care 
• Equip EMS personnel and response vehicles with 
pediatric-specific equipment and medications. This 
includes supplies for decontamination and assess-
ment/treatment for biological, chemical, and radio-
logical terrorism. 
• Establish model guidelines and best practices for 
communication, documentation, community involve-
ment, equipment, medical oversight, and strong In-
cident Command Systems, protocols for basic life 
support and advanced life support, children with 
special health-care needs, and schools (both public 
and private). 
anthrax vaccine (Anthrax Vaccine Adsorbed, AVA, Bio-
port, Lansing, Mich.) is approved only for people 18-65 
years old. This vaccine may have a limited role as an ad-
junct to postexposure chemoprophylaxis, although data 
are limited. There is only limited potential for use of this 
vaccine in a civilian pre-exposure setting, but the partici-
pants felt that future studies of new-generation anthrax 
vaccines should include children. 
FIGURE 3. RECOMMENDATIONS FOR HOSPITAL PREPAREDNESS 
• Ensure preparedness in all hospitals, with children's 
hospitals playing a crucial role in educating the com-
munity, training health-care providers, and directing 
the care of children in general hospitals when the 
numbers of children or logistics prevent transport to a 
children's hospital. 
• Keep a 48-hour supply of pediatric equipment and 
pharmaceuticals on hand for the average daily num-
ber of patients plus an additional 100 patients. 
• Include a detailed pediatric component in Web-based 
hospital resource availability networks. 
• Engage in a pediatric-specific disaster risk assessment 
with the community, including school districts, the of-
fice of emergency services, EMS, the police depart-
ment, the fire department, private practitioners, child 
welfare organizations, childcare establishments, public 
health organizations, and mental health facilities. 
• Develop informational resources and training for pe-
diatric-specific responses to biological, chemica], and 
radiological terrorism. 
• Ensure that all hospital emergency operations and 
preparedness policies include pediatric care and treat-
ment guidelines and account for the unique aspects 
and needs of children. 
• Ensure that all agents and equipment that are stocked 
for disaster and terrorism preparedness are either 
specifically for pediatric use or can be appropriately 
substituted for pediatric use. 
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FIGURE 4. RECOMMENDATIONS FOR SPECIALTY RESOURCE CENTERS, METROPOLITAN MEDICAL RESPONSE SYSTEMS, 
COMMUNITY RESPONSE TEAMS, AND PHYSICIAN VOLUNTEERS 
• Designate a pediatric specialty resource center and 
system in every regional and state disaster plan to in-
clude-at a minimum-pediatric critical care, pedi-
atric trauma, and pediatric bum capabilities. 
• Form disaster medical and psychological incident re-
sponse teams capable of managing pediatric patients in 
every region. The Metropolitan Medical Response Sys-
tem (MMRS) and Community Response Teams must 
plan for and receive training in the care of pediatric pa-
tients. The MMRS must include appropriately trained 
providers and provision for pediatric equipment. 
• Promote communication and consultation between 
facilities by availability of multiple horizontal com-
munication systems that include patient records and 
medical information. 
• Involve pediatric-trained providers in physician vol-
unteer programs. Such programs must have plans to 
provide pediatric-trained providers to facilities that 
need additional support in disaster events. 
• Fund regional planning efforts. 
• Develop multiple systems capable of transporting pe-
diatric patients to link patient care resources. 
TABLE 1. RECOMMENDED THERAPY AND PROPHYLAXIS OF ANTHRAX IN CHILDREN 
Form of anthrax 
Inhalational 
Inhalational 
Category of treatment 
(therapy or prophylaxis) 
Therapya 
Patients who are clinically 
stable after 14 days can be 
switched to a single oral 
agent (ciprofloxacin or 
doxycycline) to complete a 
60-day courseb of therapy. 
Post-exposure prophylaxis 
(60-day courseb) 
Cutaneous, endemic Therapyg 
Cutaneous (in setting Therapyg 
of terrorism) 
Gastrointestinal Therapya 
Agent and dosage 
Ciprofloxacinc 10-15 mglkg IV ql2h (max 400 mg/dose) 
or 
Doxycycline 2.2 mg/kg IV (max 100 mg) q 12h 
and 
Clindamycind 10-15 mglkg IV q8h 
and 
Penicillin GC 250-600k u/kg/d IV divided q4h 
Ciprofloxacinf 10-15 mg/kg PO 
(max 500 mg/dose) ql2h 
or 
Doxycycline 2.2 mglkg (max 100 mg) PO q 12h 
Penicillin V 25-50 mglkg/d PO divided q6h or 
Amoxicillin 40-80 mg/kg/d PO divided q8h or 
Ciprofloxacin 10-15 mg/kg PO (max I gm/day) ql2h or 
Doxycycline 2.2 mg/kg PO (max 100 mg) q 12h 
Ciprofloxacin 10-15 mg/kg PO (max 1 gm/day) qI2h or 
Doxycycline 2.2 mglkg PO (max 100 mg) q12h 
Same as for inhalational 
This table was created from recommendations developed at the consensus conference and is based in part on reviewed reference 
materials from AAP, CDC, FDA, and IDSA. 
Uln a mass casualty setting, in which resources are severely limited, oral therapy may need to be substituted for the preferred par-
enteral option. This may be most acceptable for ciprofloxacin, because it is rapidly and well absorbed from the gastrointestinal tract 
with no substantial loss from first-pass effect. 
bChiIdren may be switched to oral amoxicillin (40-80 mglkgld divided q8h) to complete a 60-day course (assuming the organ-
ism is sensitive). We recommend that the first 14 days of therapy or postexposure prophylaxis, however, inc1ude ciprotloxacin 
and/or doxycycline regardless of age. A three-dose series of vaccine may permit shortening of the antibiotic course to 30 days. 
cLevotloxacin or ofloxacin may be acceptable alternatives to ciprofloxacin. 
<IRifampin or c1arithromycin may be acceptable alternatives to clindamycin as drugs that target bacterial protein synthesis. If 
ciprofloxacin or another quinolone is used, doxycycline may be used as a second agent because it also targets protein synthesis. 
cAmpicillin, imipenem, meropenem, or chloramphenicol may be acceptable alternatives to penicillin as drugs with good CNS 
penetration. 
f According to most experts, ciprofloxacin is the preferred agent for oral prophylaxis. 
STen days of therapy may be adequate for endemic cutaneous disease. However, a full 60-day course is recommended in the set-
ting of terrorism because of the possibility of concomitant inhalational exposure. 
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TABLE 2. RECOMMENDED THERAPY AND PROPHYLAXIS IN CHILDREN FOR ADDITIONAL SELECT 


















Treatment, agent, and dosage ll 
Supportive care 
Vaccination may be effective if given within the first several 
days after exposure. 
Gentamicin 2.5 mg/kg IV q8h or 
Streptomycin 15 mg/kg 1M q12h (max 2 gmJday, although 
only available for compassionate usage and in limited 
supply is a preferred agent) or 
Doxycycline 2.2 mglkg IV q12h (max 200 mg/day) or 
Ciprofloxacin 15 mglkg IV q12h or 
Chloramphenicolb 25 mglkg q6H (max 4 gmJday) 
Doxycycline 2.2 mg/kg PO q 12h or 
Ciprofloxacinc 20 mglkg PO q 12h 
Same as for plague 
Supportive care, antitoxin may halt progression of symptoms 
but is unlikely to reverse them 
Supportive care, ribavirin may be beneficial in select casesd 
TMP/SMX 30 mg/kg PO q12h and Rifampin 15 mglkg q24h 
or Gentamicin 7.5 mglkg 1M qdx5 
This table was created from recommendations developed at the consensus conference and is based in part on reviewed reference 
materials from AAP, CDC, and IDSA. 
DIn a mass casualty setting. parenteral therapy might not be possible. In such cases. oral therapy (with analogous agents) may 
need to be used. 
bConcentration should be maintained between 5 and 20 mcglmL. Some experts have recommended that chloramphenicol be 
used to treat patients with plague meningitis, because chloramphenicol penetrates the blood-brain barrier. Use in children younger 
than 2 years old may be associated with adverse reactions but might be warranted for serious infections. 
COther f1uoroquinolones (Ievofloxacin. ofloxacin) may be acceptable substitutes for ciprofloxacin; however. they are not ap-
proved for use in children. 
dRibavirin is recommended for arenavirus and bunyavirus and may be indicated for a viral hemorrhagic fever of an unknown eti-
ology, although it is not FDA approved for these indications. For intravenous therapy use a loading dose: 30 kg IV once (maximum 
dose, 2 gm), then 16 mglkg IV every 6 hr for 4 days (maximum dose. I gm) and then 8 mglkg IV every 8 hr for 6 days (maximum 
dose, 500 mg). In a mass casualty setting, it may be necessary to use oral therapy. For oral therapy. use a loading dose of 30 mglkg 
PO once, then 15 mglkglday PO in 2 divided doses for 10 days. 
cFor children younger than 8 years. For children older than 8 years, adult regimens are recommended. Oral drugs should be given for 
6 weeks. Gentamicin. if used. should be given for the first 5 days of a 6-week course of TMP/SMX (trimethoprimlsulfamethoxazole). 
The currently licensed smallpox vaccine (Dryvax, Wyeth, 
Philadelphia, Penn.) makes no mention in its package insert 
of an approved age range. This vaccine was routinely ad-
ministered to l-year-olds before the early 1970s. The Cen-
ters for Disease Control and Prevention (CDC) currently 
recommends against vaccination of children younger than I 
year. However, all contraindications to smallpox vaccina-
tion are relative. After bona fide exposure or known usage 
of weaponized smallpox, even the youngest exposed or at-
risk infants should be vaccinated. Moreover, future studies 
of new-generation vaccines must include children. 
A licensed tri,valent (types A, B, E) botulism antitoxin 
is available through the CDC. This antitoxin is to be used 
in children of any age known to have been exposed to bot-
ulinum toxin of the appropriate serotypes. An IND pen-
tavalent (types A-E) Botulinum Immune Globulin (hu-
man) is available through the California Department of 
Health and is specifically for the treatment of infantile 
botulism. The panel concluded that study of this product 
should be continued and licensure pursued. No licensed 
plague vaccine is currently in production. A previously li-
censed vaccine was approved only for people 18-61 years 
old. However, there is little, if any, role for this vaccine or 
similar vaccines in the context of a bioterrorist attack. 
Chemical terrorism. Figures 3 and 4 summarize the 







































Vapor: fresh air, remove 
clothes, wash hair 
Liquid: remove clothes, 
copious washing of skin 
and hair with soap and 
water, ocular irrigation 
Skin: soap and water 
Eyes: irrigation (water) 
Both: major impact 
only if done within 
minutes of exposure 
Management 
Airway, breathing, circulatory support 
Atropine 0.05-0.1 mglkg IVb, IMe (min 
0.1 mg, max 5 mg) repeat q2-5 min pm 
for marked secretions, bronchospasm, 
hypoxia, respiratory compromise, apnea, 
cardiopulmonary arrest 
Pralidoxime 25-50 mglkg IV,IMd 
(max I g IV; 2 g 1M), may repeat within 
30-60 min pm, then again qlh for 1 or 2 
doses pm for persistent weakness, high 
atropine requirement 
Diazepam 0.05-O.3mglkg (max 10 mg) 
IV, lorazepam 0.1 mglkg IV or 1M 
(max 4 mg), midazolam 0.1-0.2 mglkg 
(max 10 mg) 1M pm for seizures or 
severe exposure 
Symptomatic care 
Possibly British anti-lewisite (BAL) 3 mglkg 
1M q4-6 h for systemic effects of 












CS, CN (Mace®) Neuropeptide 
capsaicin substance P 
(pepper spray) release, 
alkylation 










Eye: tearing, pain, 
blepharospasm 










Seconds Fresh air 
Skin: soap and water 
Seconds Fresh air 
Eye: irrigation (water) 
Symptomatic care 
Airway, breathing, circulatory support; 
100% oxygen 
Sodium bicarbonate pm for metabolic 
acidosis 





Maximum 10 ml 
Estimated Hgb (gldl) 




Sodium thiosulfate (25%) 1.65 ml/kg 
(maximum 50 ml) 
Topical ophthalmics, symptomatic care 
3Decontamination, especially for patients with significant exposure to nerve agents or vesicants, should be performed by health care providers dressed in adequate personal protective 
equipment. For emergency department staff, this consists of a non-encapsulated. chemically resistant body suit. boots. and gloves with a full-face air purifier masklhood. 
blntraosseous route is likely equivalent to intravenous. 
CAtropine might have some benefit via endotracheal tube or inhalation. as might aerosolized ipratropium. 
dpralidoxime is reconstituted to 50 mg/ml (I g in 20 ml water) for IV administration. and the total dose is infused over 30 min. or it may be given by continuous infusion (loading dose 25 
mglkg over 30 min, then 10 mglkglhr). For 1M use. it might be diluted to a concentration of 300 mglml (1 g added to 3 ml water-by analogy to the Mark 1 autoinjector concentration). to ef-
fect a reasonable volume for injection. Key: Hgb = hemoglobin; pm = as needed. 
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agents. Panel recommendations were based on the pre-
sented data and the breakout group discussions. The con-
sensus panel agreed that all plans for providing medica-
tions in the case of a terrorism event should include all 
agents listed in Tables 3 and 4, including appropriate pe-
diatric forms and dosages. This would include stocking 
and deployment of these agents through the SNS and 
state and local health departments (push packs, vendor-
managed inventory, etc.). The panel also agreed that 
there should be treatment provisions for local responders 
and that adequate stocks of antidotes (especially for 
nerve agents) should be available for use by EMS and 
hospital emergency departments. The panel also noted 
the need to have stocks of cyanide antidote, along with 
clear, size-adjusted dosing regimens. The panel further 
concluded that risk assessment should be used to deter-
mine the quantity of stock items, based on the estimated 
numbers of all possibly exposed children and estimates 
of children being transported for treatment. 
One of the key evidence-based conclusions of the panel 
was support for use of the Mark-1 Autoinjector kits in 
cases of chemical terrorism with nerve agents. These kits 
are not currently approved for pediatric use. However, the 
panel concluded that they provide good initial treatment 
for children with severe, life-threatening nerve agent tox-
icity when IV treatment is not possible or available, or 
when more precise 1M (mglkg) dosing would be logisti-
cally impossible. The panel also concluded that U.S. ap-
proval of a pediatric autoinjector kit that is currently pro-
duced and marketed abroad should be expedited. 
Further, the U.S. should strongly consider developing a 
universal, length-based dosing system (such as the 
Luten-Broselow color coding paradigm) for chemical 
agent antidotes and other critical medications for use in 
terrorism events. 
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The panel noted that educational material on pediatric 
treatment for chemical terrorism is limited. As such, the 
panel found a need for an organized body of knowledge 
regarding chemical weapons and children. This educa-
tional material should be readily available to pediatric 
and emergency services health-care professionals and 
should include information about the known pediatric 
toxicology of chemical weapons, management protocols 
based on a consensus guideline-development process, 
and real-time contact resources (e.g., poison control cen-
ters, CDC, etc.). In addition, the panel concluded that ed-
ucational programs on chemical terrorism should be 
made available to EMS and community health-care 
workers (e.g., school nurses). These programs should be 
part of an ongoing training and assessment process. 
Radiological terrorism. A key panel recommendation 
was to plan for and develop distribution systems for KI 
[potassium iodide] in all localities. The panel noted that 
KI is a valuable treatment for children exposed to ra-
dioiodines. Local areas should have the capability of be-
ing able to treat all children with KI within 2 hours of ex-
posure to radioactive iodine. Community risk assessment 
should be used to determine the potential need for KI, 
based on the estimated pediatric population that could be 
exposed to a minimum of ScGy radioactive iodine. Typi-
cally, this at-risk population resides within at least a 10-
mile radius of a release, although a SO-mile radius is pos-
sible under some conditions. 
The panel recommended graded KI dosing based on age 
(Table S) whenever possible. If local emergency planners 
conclude that graded dosing is logistically impractical for 
populations at risk of radioiodine exposure, then 130 mg 
of KI should be administered. The overall benefits of re-
ceiving 130 mg of KI instead of the lower doses recom-
mended for certain age groups far exceed the small risks 
TABLE 4. AUTOINJECTOR USAGE 
Number of Atropine Pralidoxime 
Approximate Approximate autoinjectors dosage range dosage range 
age weight (each type) (mg/kg) (mg/kg) 
3-7 yrs 13-2S kg I 0.08-0.13 24-46 
8-14 yrs 26-S0 kg 2 0.08-0.13 24-46 
>14 yrs >Sl kg 3 0.11 or less 35 or less 
Note: Each Mark-l kit contains two autoinjectors (0.8-inch needle insertion depth), one each of atropine 2 mg (0.7 ml) and prali-
doxime 600 mg (2 ml); while not approved for pediatric use, they should be used as initial treatment in circumstances for children 
with severe, life-threatening nerve agent toxicity for whom IV treatment is not possible or available or for whom more precise 1M 
(mglkg) dosing would be logistically impossible. Suggested dosing guidelines are offered; note potential excess of initial atropine 
and pralidoxime dosage for age/weight, although within general guidelines for recommended total over first 60-90 min of therapy 
for severe exposures. This table lists usage of the Mark-l kit only down to age 3 based on adherence to recommended dosages/or 
atropine and pralidoxime. However, if an adult Mark-l kit is the only available source of atropine and pralidox;me after a bona 
fide nerve agent exposure, it should be administered to even the youngest child. 
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TABLE 5. DOSE GUIDELINES FOR KI ADMINISTRATION 
Patient/Age 
>40 years of age 
18-40 years of age 
12 through 17 years of age 
4 through 11 years of age 
1 month through 3 years of age 
Birth through I month of age 
Pregnant or lactating women 
















This table was created from recommendations developed at the consensus conference and is based 
in part on reviewed reference materials from AAP, CDC, and FDA. 
aChildren/adolescents weighing more than 70 kg should receive the adult dose (130 mg). 
of overdosing. Similarly, KI dosing based on projected 
thyroid radioactive exposure may be logistically impracti-
cal during a radiological emergency. In this case, KI 
should be administered to children to protect them from at 
least a 0.05 Gy projected internal thyroid exposure. 
The panel agreed that the government should facilitate 
development of a pediatric preparation of KI, in an effort 
to make pediatric dosing more practical. In general, the 
KI dosing should follow the recommendations in Table 5 
and Figures 5 and 6, except as noted above. 
The panel noted a need for appropriate agents, in addi-
tion to KI, for radiological events, including agents to 
stimulate bone marrow. These agents are important for 
children who may be victims of radiological terrorism or 
who may be exposed to radioactive materials through a 
nonterrorist event. Recommendations based on available 
marrow-stimulative agents and their dosages are listed in 
Table 6. The panel also agreed that medication stockpiles 
should include adequate stocks of anti-emetics to treat 
the emesis caused by this exposure and to prevent dehy-
dration, to which children have increased susceptibility. 
Finally, the panel agreed on the need to stock the med-
ications for treatment of radiological exposure by agents 
other than radioactive iodine. These agents and the rec-
ommended treatments are listed in Table 7. Furthermore, 
children should always be considered in testing of these 
agents and agents to be developed in the future and their 
treatment protocols. 
Physical protection. There is little role for physical 
protection (e.g., personal protection devices) against 
bioterrorist agents in a civilian population. Although 
some companies are marketing devices such as gas 
masks for children, the panel felt that the risks of using 
these are likely to outweigh the benefits. For example, re-
ports exist of Israeli children suffocating after donning 
gas masks during Operation Desert Storm. However, re-
search into future means of physical protection must con-
sider the needs of children. 
FIGURE 5. GUIDELINES FOR HOME PREPARATION OF KI SOLUTION USING 130-MG TABLET 
I. Put one 130-mg KI tablet in a small bowl and grind into a fine powder with the back of a spoon. The 
powder should not have any large pieces. 
2. Add 4 tsp (20 mL) of water to the KI powder. Use a spoon to mix them together until the KI powder is 
dissolved in the water. 
3. Add 4 tsp (20 mL) of milk, juice, soda, or syrup (e.g., raspberry) to the Kliwater mixture. Potassium 
iodide mixed with any of the recommended drinks will keep for up to 7 days in the refrigerator. 
4. The resulting mixture is 16.25 mg of KI per teaspoon (5 mL). 
5. Age-based dosing guidelines: 
Newborn through I month of age= 1 tsp 
I month through 3 years of age=2 tsp 
4 years through 17 years of age=4 tsp (Children/adolescents weighing more than 70 kg should 
receive one 130-mg tablet.) 
This figure was created from recommendations developed at the consensus conference and is based in part on reviewed ref-
erence materials from AAP. CDC, and FDA. 
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FIGURE 6. GUIDELINES FOR HOME PREPARATION OF KI SOLUTION USING 65-MG TABLETII 
1. Put one 65-mg KI tablet in a small bowl and grind into a fine powder with the back of a spoon. The 
powder should not have any large pieces. 
2. Add 4 tsp (20 mL) of water to the KI powder. Use a spoon to mix them together until the KI powder is 
dissolved in the water. 
3. Add 4 tsp (20 mL) of milk, juice, soda, or syrup (e.g., raspberry) to the KUwater mixture. Potassium 
iodide mixed with any of the recommended drinks will keep for up to 7 days in the refrigerator. 
4. The resulting mixture is 8.125 mg of KI per teaspoon (5 mL). 
5. Age-based dosing guidelines: 
Newborn through 1 month of age = 2 tsp 
1 month through 3 years of age = 4 tsp 
4 years through 17 years of age = 8 tsp or one 65-mg tablet (Children/adolescents weighing more than 
70 kg should receive two 65-mg tablets.) 
This figure was created from recommendations developed at the consensus conference and is based in part on reviewed ref-
erence materials from AAP, CDC, and FDA. 
Decontamination. The panel discussed the need to de-
sign decontamination systems so that they can be used 
for children of all ages (including infants). These systems 
should include pediatric considerations related to water 
temperature and pressure (Le., high-volume, low-pres-
sure, heated water systems), non ambulatory children, 
parentless children, and children with special health-care 
needs. There is also a need to provide clean clothes for 
children after they have been decontaminated. In general, 
the above considerations need to be addressed in all fed-
eral, state, regional, and local protocols and guidance 
documents. 
Strategic National Stockpile. The panel concluded that 
the SNS must address the unique needs of children in 
many areas, including: 
• assuring availability of pediatric supplies in all phases 
of a disaster; 
• using age and weight considerations to allocate inven-
tory percentages; 
• providing pediatric dosing schedules and formulations; 
• providing current, individualized packing; and 
• providing pediatric expertise for the overall SNS pro-
gram, as well as during planning and implementation. 
The distribution of pediatric-specific supplies, includ-
ing the SNS, should be coordinated in state, regional, and 
local disaster plans. The SNS must require external re-
view by a federal multidisciplinary pediatric advisory 
board for all federal, state, regional, and local equipment 
and pharmaceutical stockpiles. 
CONCLUSIONS 
The consensus-building process described above rep-
resented a major step forward in pediatric preparedness 
for disaster and terrorist events. This process resulted in a 
set of recommendations and guidelines to address the 
particular vulnerabilities of children to terrorist attacks or 
TABLE 6. MARROW STIMULATIVE AGENTS 
Agent 






Stimulating Factor (GCSF) 
Colony 
Stimulating Factor (AMCSF) 
Dosageb 
150 unitslkgldose 
2.5-5 mcglkglday (dosages of 20 mcglkglday 
may be needed in selected patients) 
5-10 mcglkglday (dosages of 30 mcglkglday 
may be needed in selected patients) 
aEpoetin Alpha may also be useful to reduce the overall requirements for blood transfusion in any mass casualty incident. 
bDosage derived from Medical Management of Radiological Casualties, Armed Forces Radiobiology Research Institute, 1999, 
and accepted dosages for pediatric oncology and pediatric congenital neutropenia and erythropenia patients. 
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TABLE 7. RADIONUCLIDES PRODUCED AFTER RADIOLOGICAL TERRORISM OR DISASTER-INTERNAL 
CONTAMINATION, TOXICITY, AND TREATMENT1•2•13 
Respiratory Skin wound 
Element absorption GI absorption absorption Primary toxicity Treatment 
Americium 75% Minimal Rapid Skeletal deposition Chelation with DTP A 
Marrow suppression, or EDTA 
hepatic deposition 
Cesium Complete Complete Complete Whole body Prussian blue 
irradiation 
Cobalt High <5% Unknown Whole body Supportive 
irradiation 
Iodine High High High Thyroid ablation, Potassium iodide 
carcinoma 
Phosphorus High High High Bone, rapidly Aluminum hydroxide 
replicating cells 
Plutonium High Minimal Limited, may Lung, bone, liver Chelation with DTP A 
form nodules or EDTA 
Radium Unknown 30% Unknown Bone, marrow Magnesium sulfate 
suppression, sarcoma lavage 
Strontium Limited Moderate Unknown Bone Supportive 
Tritium Minimal Minimal Complete Panmyelocytopenia Dilution with controlled 
water intake, diuresis 
Tritiated water Complete Complete Complete Panmyelocytopenia Dilution with controlled 
water intake, diuresis 
Uranium High High to High absorption, Pulmonary, Chelation with DTPA 
moderate skin irritant nephrotoxic or EDT A, NaHC03 to 
disasters, as well as possible responses to these scenarios. 
However, the development of these recommendations 
and guidelines is only the first step in improving disaster 
and terrorism preparedness for children. The next step is 
to ensure that these recommendations reach the individu-
als with the authority to make decisions regarding their 
adoption, as well as those who wiJ] be putting them into 
use. 
In the future, we need to enhance our know ledge base 
regarding children's needs. This will require funding of 
the research agenda by Congress, the National Institutes 
of Health, and other federal agencies responsible for pre-
paredness. We plan to reconvene this panel in one year to 
evaluate the current state of implementation of the rec-
ommendations and guidelines, to update the recommen-
dations as needed based on new research, and to plan the 
continuing research agenda. 
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